NCT00185133

Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension

A Randomized, Double-blind, Placebo-controlled Factorial Study Evaluating the Efficacy and Safety of Co-administration of Olmesartan Medoxomil Plus Amlodipine Compared to Monotherapy in Patients With Mild to Severe Hypertension

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 1,900 (planned)
• Sponsor: Daiichi Sankyo · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study assesses the efficacy and safety of co-administration of olmesartan medoxomil plus amlodipine in mild to severe hypertensive patients older than 18 years of age

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	Olmesartan medoxomil
DRUG	Amlodipine

Timeline

• Start date: 2005-05-01
• Completion: 2007-01-01
• First posted: 2005-09-16
• Last updated: 2018-12-24

Locations

139 sites across 1 country: United States